Advair Not Likely To Be Displaced With Launch Of New Product
According to the new Pharmacor report titled "Asthma," the launch of the once-daily emerging therapy indacaterol/mometasone--estimated to achieve blockbuster status in 2016--will not displace Advair/Seretide, the current market leader, which generated sales of more than $3 billion in 2006 in the world's major pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan).
Despite the future blockbuster status of several drugs, the increased cost-consciousness in many markets combined with the impending arrival of multiple lower-priced emerging therapies will result in only modest annual growth in the asthma market from 2006 to 2011, and a small decline in its growth between 2011 and 2016.
The report also finds that the emerging biologic agents Amgen/Wyeth/Takeda's Enbrel, Centocor/Schering-Plough/Tanabe/Janssen Pharmaceuticals' golimumab, Abbott/Eisai's Humira, and PDL BioPharma's Zenapax will generate $785 million in sales in 2016.
"These high-priced emerging biologics will generate significant major market sales despite the small eligible patient population that will receive such agents--severe asthmatics who do not respond to conventional therapy," said Madhuri Borde, Ph.D., analyst at Decision Resources, via a press release.
Recent Marketing Daily Articles
-
Hasbro Launches Nerf Dog June 20, 12:04 a.m.
Hasbro Inc. is partnering with Gramercy Products, Inc. to launch Nerf Dog, a full range of ... -
Affluent Consumers Continue Spending June 19, 4:53 p.m.
Attribute it to an improving economy, or simply fatigue in behaving a certain way, but the ... -
Voss Water In Socially Driven Summer Campaign June 19, 3:27 p.m.
Voss Water has launched a social-plus-retail summer campaign designed to engage consumers and strengthen relations with ... -
Chevy Back With MOFILM For Oscars June 19, 3:22 p.m.
Chevrolet has tied a five-year knot with the Oscars, with attention on independent filmmakers. Chevrolet’s theme ... -
Nissan Opens Door To Versa Launch June 19, 2:18 p.m.
Nissan’s new Versa Note is a "A Door to More" in the automaker’s campaign for the ... -
Saks Fifth Avenue Rolling Out New Campaign June 19, 11:12 a.m.
Saks Fifth Avenue is debuting a new marketing campaign, which it hopes will sell shoppers on ... -
JetBlue, Marriott Top Their Industries June 19, 12:23 a.m.
Just as the summer travel season heats up, the American Customer Satisfaction Index (ACSI) has released ... -
Evian Launches Wimbledon 'Wiggle' Social Effort June 18, 5:20 p.m.
<Evian -- no slouch at driving buzz during the Wimbledon tournament -- has come up with ... -
GMA/PwC Report: CPGs' Growth Slows Amid 'Rules' Shift June 18, 3:56 p.m.
Net sales growth rates for consumer packaged goods (CPG) companies slowed last year amid challenges including ... -
Industry Is Expanding In Advertising, Social June 18, 12:29 p.m.
Retailers are planning to spend big on more stores, digital technology and marketing initiatives in the ...
Be the first to comment on "Advair Not Likely To Be Displaced With Launch Of New Product "
Leave a Comment